These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 38107638)
1. Association of high-estimated glomerular filtration rate with the severity of ischemic stroke during non-vitamin K antagonist oral anticoagulants therapy: a nationwide cohort study. Kang MK; Lee D; Oh MS; Lee JS; Jeong HY; Shin JH; Yoon BW; Park JM Front Neurol; 2023; 14():1277855. PubMed ID: 38107638 [TBL] [Abstract][Full Text] [Related]
2. Association of high estimated glomerular filtration rate with risk of atrial fibrillation: a nationwide cohort study. Kang MK; Ha HJ; Jung R; Oh Y; Kim DH; Song TJ Front Med (Lausanne); 2023; 10():1207778. PubMed ID: 37692776 [TBL] [Abstract][Full Text] [Related]
3. Variability in Non-Vitamin K Antagonist Oral Anticoagulants Dose Adjustment in Atrial Fibrillation Patients With Renal Dysfunction: The Influence of Renal Function Estimation Formulae. Andrade JG; Hawkins NM; Fordyce CB; Deyell MW; Er L; Djurdjev O; Macle L; Virani SA; Levin A Can J Cardiol; 2018 Aug; 34(8):1010-1018. PubMed ID: 29980468 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes in elderly atrial fibrillation patients at increased bleeding risk treated with very low dose vs. regular-dose non-vitamin K antagonist oral anticoagulants: a nationwide cohort study. Chan YH; Chao TF; Chen SW; Lee HF; Li PR; Yeh YH; Kuo CT; See LC; Lip GYH Eur Heart J Cardiovasc Pharmacother; 2023 Dec; 9(8):681-691. PubMed ID: 37580139 [TBL] [Abstract][Full Text] [Related]
5. Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function. Lee SR; Choi EK; Han KD; Jung JH; Cha MJ; Oh S; Lip GYH Stroke; 2019 Jun; 50(6):1480-1489. PubMed ID: 31084339 [TBL] [Abstract][Full Text] [Related]
6. Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation. Xian Y; O'Brien EC; Liang L; Xu H; Schwamm LH; Fonarow GC; Bhatt DL; Smith EE; Olson DM; Maisch L; Hannah D; Lindholm B; Lytle BL; Pencina MJ; Hernandez AF; Peterson ED JAMA; 2017 Mar; 317(10):1057-1067. PubMed ID: 28291892 [TBL] [Abstract][Full Text] [Related]
7. Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment. Hawkins NM; Jhund PS; Pozzi A; O'Meara E; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; Petrie MC; Virani S; McMurray JJ Eur J Heart Fail; 2016 Sep; 18(9):1162-71. PubMed ID: 27594177 [TBL] [Abstract][Full Text] [Related]
8. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage. Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848 [TBL] [Abstract][Full Text] [Related]
9. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study. Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K; Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811 [TBL] [Abstract][Full Text] [Related]
10. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP; Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380 [TBL] [Abstract][Full Text] [Related]
11. Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation. Yao X; Tangri N; Gersh BJ; Sangaralingham LR; Shah ND; Nath KA; Noseworthy PA J Am Coll Cardiol; 2017 Nov; 70(21):2621-2632. PubMed ID: 29169468 [TBL] [Abstract][Full Text] [Related]
12. CHA Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672 [TBL] [Abstract][Full Text] [Related]
13. Initial Stroke Severity in Patients With Atrial Fibrillation According to Antithrombotic Therapy Before Ischemic Stroke. Jung YH; Kim YD; Kim J; Han SW; Oh MS; Lee JS; Lee KY Stroke; 2020 Sep; 51(9):2733-2741. PubMed ID: 32811392 [TBL] [Abstract][Full Text] [Related]
14. [Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation]. Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C G Ital Nefrol; 2017 Apr; 34(2):58-73. PubMed ID: 28682563 [TBL] [Abstract][Full Text] [Related]
15. Effect of prior anticoagulation therapy on stroke severity and in-hospital outcomes in patients with acute ischemic stroke and atrial fibrillation. Zhou L; Li Y; Yang X; Gu H; Duan Y; Fu H; Wang A; Liu K; Gao Y; Song B; Li Y; Jiang Y; Zhang J; Wang C; Wang M; Li Z; Xu Y; Wang C; Wang Y Int J Cardiol; 2023 Aug; 385():62-70. PubMed ID: 37257512 [TBL] [Abstract][Full Text] [Related]
16. Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function : Post hoc analysis of a prospective cohort. Malavasi VL; Pettorelli D; Fantecchi E; Zoccali C; Laronga G; Trenti T; Lip GYH; Boriani G Intern Emerg Med; 2018 Oct; 13(7):1059-1067. PubMed ID: 29736630 [TBL] [Abstract][Full Text] [Related]
17. Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality. Inohara T; Xian Y; Liang L; Matsouaka RA; Saver JL; Smith EE; Schwamm LH; Reeves MJ; Hernandez AF; Bhatt DL; Peterson ED; Fonarow GC JAMA; 2018 Feb; 319(5):463-473. PubMed ID: 29372247 [TBL] [Abstract][Full Text] [Related]
18. Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase. Kam W; Holmes DN; Hernandez AF; Saver JL; Fonarow GC; Smith EE; Bhatt DL; Schwamm LH; Reeves MJ; Matsouaka RA; Khan YM; Unverdorben M; Birmingham MC; Lyden PD; Asimos AW; Altschul D; Schoonover TL; Jumaa MA; Nomura JT; Suri MFK; Moore SA; Lafranchise EF; Olson D; Peterson ED; Xian Y JAMA; 2022 Feb; 327(8):760-771. PubMed ID: 35143601 [TBL] [Abstract][Full Text] [Related]
19. Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage. Lee SR; Choi EK; Kwon S; Jung JH; Han KD; Cha MJ; Oh S; Lip GYH Stroke; 2020 Feb; 51(2):416-423. PubMed ID: 31813363 [TBL] [Abstract][Full Text] [Related]
20. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study. Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M; Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]